bioMérieux Recognized as Top 1% by S&P Global
March 27, 2025
bioMérieux is honored to be recognized in the top 1% of the S&P Global Sustainability Yearbook 2025, achieving a score of 70/100 in the Health Care Equipment & Supply segment. Out of 7,690 assessed companies across 62 industries, only 780 top performers have received this distinction, highlighting their excellence in sustainable business practices.
Furthermore, bioMérieux was ranked 1st in the sector of healthcare equipment and Supply by the Dow Jones Sustainability Index (DJSI) through the S&P Global Corporate Sustainability Assessment. bioMérieux first joined the DJSI in 2021 and has proudly risen to the top position in just four years! This recognition underscores the company’s strong commitment to Corporate Social Responsibility, reinforcing its mission to create a positive impact worldwide while preserving the planet as a healthy place to live.
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS